Scientific Sessions 2024  /  Emerging Therapies for Treatment of Hypertension and Chronic Kidney Disease  /  RNA based angiotensinogen inhibitors- a promising new treatment?
Logo

American Heart Association

  2
  0

Final ID:

RNA based angiotensinogen inhibitors- a promising new treatment?

  • Bhalla, Vivek  ( STANFORD UNIVERSITY , Palo Alto , California , United States )
    • Author Disclosures:
    Vivek Bhalla: DO have relevant financial relationships ; Advisor:Bayer:Active (exists now) ; Research Funding (PI or named investigator):AHA:Active (exists now) ; Research Funding (PI or named investigator):NIDDK:Active (exists now) ; Ownership Interest:Pyrames:Active (exists now) ; Ownership Interest:Nephrogen:Active (exists now) ; Consultant:Nephrogen:Active (exists now) ; Advisor:Janssen:Past (completed) ; Advisor:Relypsa:Past (completed) ; Advisor:Medtronic:Active (exists now) ; Advisor:Astra Zeneca:Active (exists now) ; Advisor:Idorsia:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Emerging Therapies for Treatment of Hypertension and Chronic Kidney Disease

Friday, 11/15/2024 , 04:00PM - 05:15PM

Cardiovascular Seminar

More abstracts on this topic:
Aldosterone synthase inhibitors: new kids on the block

Turcu Adina, Vaidya Anand

Non-steroidal MRAs- where do they fit in our HTN treatment toolbox?

Vongpatanasin Wanpen, Kirabo Annet

More abstracts from these authors:
Who and When to Screen?

Bhalla Vivek

You have to be authorized to contact abstract author. Please, Login
Not Available